BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/23/2022 1:56:15 PM | Browse: 171 | Download: 417
Publication Name World Journal of Virology
Manuscript ID 76706
Country/Territory India
2022-03-27 12:03
Peer-Review Started
2022-03-27 12:04
To Make the First Decision
Return for Revision
2022-05-31 17:32
2022-06-30 11:39
Second Decision
2022-09-26 03:46
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-10-04 22:47
Articles in Press
2022-10-04 22:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
2022-08-31 21:08
Typeset the Manuscript
2022-11-11 15:55
Publish the Manuscript Online
2022-11-23 13:56
ISSN 2220-3249 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Minireviews
Article Title Dipeptidyl peptidase 4 inhibitors in COVID-19: Beyond glycemic control
Manuscript Source Invited Manuscript
All Author List Niya Narayanan, Dukhabandhu Naik, Jayaprakash Sahoo and Sadishkumar Kamalanathan
Author(s) ORCID Number
Niya Narayanan http://orcid.org/0000-0001-8403-7756
Dukhabandhu Naik http://orcid.org/0000-0003-4568-877X
Jayaprakash Sahoo http://orcid.org/0000-0002-8805-143X
Sadishkumar Kamalanathan http://orcid.org/0000-0002-2371-0625
Funding Agency and Grant Number
Corresponding Author Dukhabandhu Naik, MD, Additional Professor, Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, 4th floor, Super-speciality block, JIPMER campus, Dhanvantri nagar, Puducherry, India -605006 , Puducherry 605006, Puducherry, India. drnaik2000@gmail.com
Key Words Dipeptidyl -peptidase 4; Diabetes mellitus; COVID-19; Mortality
Core Tip Patients with pre-existing comorbidities, particularly diabetes mellitus (DM), are at increased risk of complications from coronavirus disease 2019 (COVID-19). Beyond their glycemic effects, Dipeptidyl-peptidase 4 inhibitors (DPP-4i) have proven effective in COVID-19 individuals with DM. Available observational studies and trials have shown a significant mortality reduction in COVID-19 patients with DM when DPP-4i were continued during the course of illness. As a result, COVID-19 individuals with DM may choose DPP-4i as the preferred anti-diabetic medication if it is not contraindicated.
Publish Date 2022-11-23 13:56
Citation Narayanan N, Naik D, Sahoo J, Kamalanathan S. Dipeptidyl peptidase 4 inhibitors in COVID-19: Beyond glycemic control. World J Virol 2022; 11(6): 399-410
URL https://www.wjgnet.com/2220-3249/full/v11/i6/399.htm
DOI https://dx.doi.org/10.5501/wjv.v11.i6.399
Full Article (PDF) WJV-11-399.pdf
Full Article (Word) WJV-11-399.docx
Manuscript File 76706_Auto_Edited-LM.docx
Answering Reviewers 76706-Answering reviewers.pdf
Audio Core Tip 76706-Audio core tip.mp4
Conflict-of-Interest Disclosure Form 76706-Conflict-of-interest statement.pdf
Copyright License Agreement 76706-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 76706-Language certificate.pdf
Peer-review Report 76706-Peer-review(s).pdf
Scientific Misconduct Check 76706-Bing-Liu JH-2.jpg
Scientific Misconduct Check 76706-CrossCheck.jpg
Scientific Editor Work List 76706-Scientific editor work list.pdf